AzurRx BioPharma, Inc. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Form of Inducement Letter (Filed With SEC on July 11, 2024)
- Form of Purchase Agreement (Filed With SEC on March 29, 2024)
- Description of Capital Stock (Filed With SEC on March 29, 2024)
- Offer Letter, dated as of March 13, 2024, by and between Dr. Syage and the Company (Filed With SEC on March 14, 2024)
- Lender Support Letter, dated as of March 13, 2024, by and between ImmunogenX and Mattress Liquidators, Inc (Filed With SEC on March 14, 2024)
- Form of Inducement Letter (Filed With SEC on December 27, 2023)
- Form of Inducement Letter (Filed With SEC on September 15, 2023)
- Form of Inducement Letter (Filed With SEC on June 16, 2023)
- Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated May 9, 2019 (Filed With SEC on May 14, 2019)
- Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated April 1, 2019 (Filed With SEC on April 3, 2019)
- AssetPurchaseAgreement, by and betweenAzurRxBioPharma, Inc.,AzurRxBioPharmaSAS andLaboratoiresMayolySpindler SAS, dated March 27, 2019 (Filed With SEC on April 1, 2019)
- Form of Partial Exercise Letter (Filed With SEC on January 5, 2018)
- Form of Exercise Letter (Filed With SEC on January 5, 2018)
- SUBLICENSE AGREEMENT (Filed With SEC on August 11, 2017)
- Registration Statement, dated April 11, 2017 (Filed With SEC on April 12, 2017)
- UNDERWRITINGAGREEMENT among AZURRXBIOPHARMA, INC. and WALLACHBETHCapital, LLC and NETWORK 1 FINANCIAL SECURITIES, INC., asRepresentatives of the Several Underwriters (Filed With SEC on October 14, 2016)
